Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)

Product Details
Customization: Available
Dossier: Ctd
Transport Package: Free
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
Manufacturer/Factory, Trading Company, Group Corporation
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (7)
  • Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
  • Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
  • Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
  • Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
  • Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
  • Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
Find Similar Products

Basic Info.

Model NO.
tablets
Specification
500mg
Trademark
Sinolead
Origin
China

Product Description

 
 

Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
Basic Info.

 
Generic Name Ciprofloxacin hydrochloride Tablets 500mg
Strength 500mg
Packing 10tablets/Blister 2blisters/Box
Origin China

Component:
Ciprofloxacin hydrochloride.

Character:

This product is a film coated sheet, after removing the coating will appear white to yellowish.


Indications:

For sensitive bacteria

(1) genitourinary infections, including simple, complex urinary tract infections, bacterial prostatitis, Neisseria gonorrhoeae urethritis or cervicitis (including those caused by enzyme producing strains).

(2) Respiratory infections, including acute episodes of bronchial infection and pulmonary infection caused by sensitive gram-negative bacilli.

(3) Gastrointestinal infection, caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, aeromonas hydrophila, Vibrio parahaemolyticus, etc.

(4) Typhoid fever.

(5) Bone and joint infections.

(6) Skin and soft tissue infection.

(7) Systemic infections such as sepsis.

 

Usage and dosage:

Take it orally.

(1) Normal adult dosage: 0.5 ~ 1.5g (2~6 tablets) per day, divided into 2~ 3 times.

(2) Bone and joint infection: 1 ~ 1.5g (4~6 tablets) a day, divided into 2 ~ 3 times, the course of treatment is 4~6 weeks or longer.

(3) Pneumonia and skin and soft tissue infection: 1 ~ 1.5g (4~6 tablets) a day, divided into 2 ~ 3 times, the course of treatment is 7 ~ 14 days.

(4) Intestinal infection: 1g (4 tablets) a day, divided into 2 times, the course of 5 to 7 days.

(5) Typhoid fever: 1.5g (6 tablets) a day, divided into 2 to 3 times, treatment of 10 to 14 days.

(6) Urinary tract infection: acute simple lower urinary tract infection, 0.5g (2 tablets) a day, divided into 2 times, the course of 5 to 7 days; Complicated urinary tract infection, 1g (4 tablets) a day, divided into 2 times, the course of treatment 7-14 days.

(7) Simple gonorrhea: a single oral dose of 0.5g (2 tablets).


Matters needing attention:

(1) Due to the current prevalence of fluoroquinolone resistance in Escherichia coli, urine culture samples should be taken before administration, and medication should be adjusted according to the bacterial drug sensitivity results.

(2) This product should be taken on an empty stomach, although the food can delay its absorption, but its total absorption (bioavailability) has not been reduced, so it can also be taken after meals to reduce gastrointestinal reactions; Drink 250ml of water at the same time.

(3) Crystalline urine can occur when the product is used in large doses or urine pH value is above 7. In order to avoid the occurrence of crystalluria, it is advisable to drink more water and keep the urine output above 1200ml for 24 hours.

(4) For patients with renal dysfunction, the dose should be adjusted according to renal function.

(5) Moderate and severe photosensitivity reactions can occur with fluoroquinolones. Excessive exposure to sunlight should be avoided when applying this product. If photosensitivity reaction occurs, discontinue the drug.

(6) When liver function is reduced, if it is severe (cirrhosis ascites), drug clearance can be reduced, blood drug concentration is increased, and liver and kidney function are reduced, which is especially obvious, and it is necessary to weigh the advantages and disadvantages of the application, and adjust the dose.

(7) People with original central nervous system disorders, such as epilepsy and epilepsy history, should avoid using, and carefully weigh the pros and cons when there are indications.
Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)

Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)
Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)Ciprofloxacin Hydrochloride Tablet 500mg (10tablets/Blister 2blisters/Box)

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier